These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 20660383
21. 123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairment. Mitsis EM, Reech KM, Bois F, Tamagnan GD, Macavoy MG, Seibyl JP, Staley JK, van Dyck CH. J Nucl Med; 2009 Sep; 50(9):1455-63. PubMed ID: 19690024 [Abstract] [Full Text] [Related]
22. Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain. Brody AL, Mandelkern MA, London ED, Khan A, Kozman D, Costello MR, Vellios EE, Archie MM, Bascom R, Mukhin AG. Arch Gen Psychiatry; 2011 Sep; 68(9):953-60. PubMed ID: 21536968 [Abstract] [Full Text] [Related]
23. [18F]FPhEP and [18F]F2PhEP, two new epibatidine-based radioligands: evaluation for imaging nicotinic acetylcholine receptors in baboon brain. Valette H, Dollé F, Saba W, Roger G, Hinnen F, Coulon C, Ottaviani M, Syrota A, Bottlaender M. Synapse; 2007 Sep; 61(9):764-70. PubMed ID: 17568410 [Abstract] [Full Text] [Related]
25. In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia. Esterlis I, Ranganathan M, Bois F, Pittman B, Picciotto MR, Shearer L, Anticevic A, Carlson J, Niciu MJ, Cosgrove KP, D'Souza DC. Biol Psychiatry; 2014 Sep 15; 76(6):495-502. PubMed ID: 24360979 [Abstract] [Full Text] [Related]
30. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain. Metaxas A, Al-Hasani R, Farshim P, Tubby K, Berwick A, Ledent C, Hourani S, Kitchen I, Bailey A. Neuropharmacology; 2013 Aug 15; 71():228-36. PubMed ID: 23583933 [Abstract] [Full Text] [Related]
31. A single administration of low-dose varenicline saturates α4β2* nicotinic acetylcholine receptors in the human brain. Lotfipour S, Mandelkern M, Alvarez-Estrada M, Brody AL. Neuropsychopharmacology; 2012 Jun 15; 37(7):1738-48. PubMed ID: 22395733 [Abstract] [Full Text] [Related]
32. Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors. Saji H, Ogawa M, Ueda M, Iida Y, Magata Y, Tominaga A, Kawashima H, Kitamura Y, Nakagawa M, Kiyono Y, Mukai T. Ann Nucl Med; 2002 May 15; 16(3):189-200. PubMed ID: 12126044 [Abstract] [Full Text] [Related]
36. Long-lasting occupancy of central nicotinic acetylcholine receptors after smoking: a PET study in monkeys. Valette H, Bottlaender M, Dollé F, Coulon C, Ottaviani M, Syrota A. J Neurochem; 2003 Jan 15; 84(1):105-11. PubMed ID: 12485406 [Abstract] [Full Text] [Related]
37. A multi-route model of nicotine-cotinine pharmacokinetics, pharmacodynamics and brain nicotinic acetylcholine receptor binding in humans. Teeguarden JG, Housand CJ, Smith JN, Hinderliter PM, Gunawan R, Timchalk CA. Regul Toxicol Pharmacol; 2013 Feb 15; 65(1):12-28. PubMed ID: 23099439 [Abstract] [Full Text] [Related]
38. Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT. Mamede M, Ishizu K, Ueda M, Mukai T, Iida Y, Fukuyama H, Saga T, Saji H. J Nucl Med; 2004 Sep 15; 45(9):1458-70. PubMed ID: 15347712 [Abstract] [Full Text] [Related]
40. Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia. D'Souza DC, Esterlis I, Carbuto M, Krasenics M, Seibyl J, Bois F, Pittman B, Ranganathan M, Cosgrove K, Staley J. Am J Psychiatry; 2012 Mar 15; 169(3):326-34. PubMed ID: 22193533 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]